Celecoxib Window of Opportunity Trial to Assess Tumor and Stroma Responses
Latest Information Update: 17 Sep 2021
At a glance
- Drugs Celecoxib (Primary)
- Indications Breast cancer; Carcinoma
- Focus Pharmacodynamics
- 11 Oct 2018 Status changed from recruiting to withdrawn prior to enrolment due to slow accrual.
- 12 Dec 2017 Status changed from not yet recruiting to recruiting.
- 06 Sep 2017 Planned initiation date changed from 30 Jun 2017 to 30 Oct 2017.